Is Astrazeneca Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSE: AZN) stock is to Buy AZN stock.
Out of 1 analyst, 0 (0%) are recommending AZN as a Strong Buy, 1 (100%) are recommending AZN as a Buy, 0 (0%) are recommending AZN as a Hold, 0 (0%) are recommending AZN as a Sell, and 0 (0%) are recommending AZN as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year AZN price target, the average AZN price target is $198.00, with the highest AZN stock price forecast at $198.00 and the lowest AZN stock price forecast at $198.00.
The Wall Street analyst predicted that Astrazeneca's share price could reach $198.00 by Aug 24, 2027. The average Astrazeneca stock price prediction forecasts a potential upside of 6.12% from the current AZN share price of $186.58.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.